Clinical Trials
11 trialsNCT04669496 2025-09-04
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Shanghai Zhongshan Hospital
Phase 2/3 Active not recruiting
NCT07134218 2025-08-21
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer
Changhai Hospital
Phase 2/3 Not yet recruiting
NCT05484024 2022-08-02
Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer
ChineseAMS
Phase 2/3 Not yet recruiting
NCT04973306 2022-06-30
iCROSS
Shanghai Zhongshan Hospital
Phase 2/3 Recruiting
NCT03623737 2022-06-07
Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC
National Taiwan University Hospital
Phase 2/3 Unknown
NCT04025437 2019-09-04
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT
Guangxi Medical University
Phase 2/3 Unknown
NCT02584556 2019-06-04
Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma
Guangxi Medical University
Phase 2/3 Withdrawn
NCT01458717 2018-05-02
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
Seoul National University Hospital
Phase 2/3 Completed
NCT00450203 2016-12-01
ST03
Medical Research Council
Phase 2/3 Unknown
NCT02882269 2016-08-30
Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2/3 Unknown
NCT01086618 2013-08-26
Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2/3 Completed